Share via Email

Jump to...

  • 0:16

    Talk Objectives

  • 1:34

    Scope of the Issue: The Numbers

  • 3:46

    Treatment Options for Menopausal Symptoms

  • 4:00

    Stages of Reproductive Aging

  • 4:49

    Stages of Reproductive Aging

  • 5:44

    MHT Risks and Benefits

  • 6:40

    Who is the Best Candidate for MHT?

  • 7:33

    Contraindications to Hormone Therapy

  • 8:16

    Patient with VMS Considering MHT: Cardiovascular Risk

  • 8:58

    Patient with VMS Considering MHT: Breast Cancer Risk

  • 9:44

    Patient with VMS Considering MHT: Uterus Present

  • 10:16

    Importance of Patient Preference

  • 11:07

    Online Assessment: MenoPro App

  • 11:37

    Transdermal may have Safety Advantages over Oral

  • 12:07

    Oral vs. Transdermal Estrogen: Risk of VTE, DVT, Stroke, MI

  • 12:50

    Custom Compounded Hormones - Guidelines

  • 13:56

    Where to Start? Mayo Clinic Best Practice

  • 15:53

    Case: 52-Year-Old Woman, G2P2, with History of Invasive Breast Cancer

  • 18:00

    Vasomotor Symptoms: Non-Hormonal Therapy Recommendations

  • 19:59

    Cognitive-Behavioral Therapy

  • 21:04

    Clinical Hypnosis

  • 22:06

    SSRI/SNRI

  • 23:17

    Gabapentinoids & Clonidine

  • 24:25

    Oxybutinin: New Studies & Trials